Prognostic value of circulating tumour cells in limited-stage small cell lung cancer: analysis of the concurrent ONce-daily versus twice-daily RadioTherapy (CONVERT) randomised controlled trial

MLA

Lynsey Priest, et al. Prognostic Value of Circulating Tumour Cells in Limited-Stage Small Cell Lung Cancer: Analysis of the Concurrent ONce-Daily versus Twice-Daily RadioTherapy (CONVERT) Randomised Controlled Trial. Jan. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9a8f7a64eb0da41234c1058673b8b4a1&authtype=sso&custid=ns315887.

APA

Lynsey Priest, Fiona H Blackhall, Fabiola Fernandez-Gutierrez, Corinne Faivre-Finn, Jacqueline Pierce, Linda Ashcroft, Katy Burns, Rebecca Tay, Karen Morris, Jonathan Tugwood, Colin R Lindsay, Victoria Foy, & Caroline Dive. (2019). Prognostic value of circulating tumour cells in limited-stage small cell lung cancer: analysis of the concurrent ONce-daily versus twice-daily RadioTherapy (CONVERT) randomised controlled trial.

Chicago

Lynsey Priest, Fiona H Blackhall, Fabiola Fernandez-Gutierrez, Corinne Faivre-Finn, Jacqueline Pierce, Linda Ashcroft, Katy Burns, et al. 2019. “Prognostic Value of Circulating Tumour Cells in Limited-Stage Small Cell Lung Cancer: Analysis of the Concurrent ONce-Daily versus Twice-Daily RadioTherapy (CONVERT) Randomised Controlled Trial,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9a8f7a64eb0da41234c1058673b8b4a1&authtype=sso&custid=ns315887.